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2227 Extracellular Enzymes, Biotypes and 
Genotypes of Oral C. albicans in Diabetics 
V. PHUNTHIKAPHADR1, C.S. TSANG2, C.S. CHU3, S.C. SIU4, L.P. SAMARANAYAKE5, W.K. LEUNG2, Y.Y. YAU2, and P. 
PHANTUMVANIT1, 1Thammasat University, Pratum-Thani, Thailand, 2The University of Hong Kong, HKSAR, China, 3The 
University of Hong Kong, China, 4Tung Wah Eastern Hospital, Hong Kong, 5The University of Hong Kong, Hong Kong, S. 
A. R, China  
Haemolysin is a relatively recently described extracellular enzyme of Candida species. Objective: The aim of this 
study therefore was to biotype, genotype and then to compare haemolysin, proteinase and phosphlipase production of 
oral Candida albicans isolates from diabetic and healthy Chinese. Method: A total of 19 each from patients with Type 
II diabetes mellitus(DM) and controls were obtained using the oral rinse technique. The yeasts were characterised 
using a biotyping and a genotyping system. The enzyme production evaluated in vitro by three different plate assays. 
Genotyping was performed by randomly amplified polymorphic DNA technique (RAPD) and the data subjected to 
computerised cluster analyses. Result: The results showed that the major biotype from the DM group and the control 
group was A1R (42.11%) and J1R(36.84%) respectively. Genotyping and dendogram analyses of RAPD gel profiles 
failed to reveal specific genotypic clusters of C.albicans associated with diabetic patients. No significant difference in 
either proteinase or phospholipase actvity was noted in isolates from the DM group compared with the controls 
(p>0.05). A significantly higher haemolysin activity was found in the control group compared with the DM group 
(p<0.05). Conclusion: The result in the haemolytic activity of C. albicans in diabetic patients, reported for the first 
time, needs to be confirmed with a larger patient group. (Supported by the Committee for Research and Conference 
Grants of the University of Hong Kong)  
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